Introduction
Salivary gland malignancies are rare, with only a fraction of these due to metastases 1, 2 . Affecting mostly males, malignancy of the parotid gland typically presents as a mass. Eighty per cent of secondary tumours involving the parotid gland originate from the head and neck region. Other origins include the lung, breast and kidney 2 .
The RCC is the most common form of kidney malignancy, with a global incidence of 15 per 100,000 of which males are more commonly affected 3 . Risk factors for developing the RCC include smoking, obesity, hypertension, end stage renal disease and tuberous sclerosis 4 . The CCRCC, the most prevalent subtype of the RCC, was recently found to be associated with the Von Hippel-Lindau (VHL) mutation 5 . Although flank pain, gross hematuria and a palpable abdominal mass constitute the classical triad of the RCC, more than 50% of cases are incidentally detected 4 .
The RCC is recognized for its unique metastasis pattern owing to its ability to spread by mainly vascular, yet also lymphatic channels 5, 6 . Well established sites for metastasis are bone, adrenals, lung and the contralateral kidney; however, metastasis to the head and neck is extremely rare 6 . We report a rare case of the CCRCC metastasizing to the parotid gland more than five years following nephrectomy.
Case Report
A 75-year-old female presented to the Oral and Maxillofacial Clinic with a left parotid mass, which had been present and growing over the period of 18 months (Figure 1 a) . The patient did not report local or systemic symptoms, such as facial paresis, change in salivation, weight loss, fever or hypertension. When acquiring past medical history, the patient reported the RCC of the left patient underwent right partial nephrectomy and autotransplantation. The patient reported a smoking history, as well as alcohol consumption, which began in her late 20s and increased to a current consumption of 3 units of alcohol per day. Clinical examination revealed a painless, hard, mobile parotid mass, measuring 4x4 cm. kidney in 2010, which presented as a one-time painless hematuria, without prior change in urination, or flank pain. Following urological assessment, the patient then underwent a left total nephrectomy. A subsequent RCC of the right kidney three years later was incidentally found during a routine follow-up examination. The 
Imaging
Neck ultrasonography (US) performed five months prior to the patient's visit to the Oral and Maxillofacial Clinic revealed a round hypoechoic lesion within the parotid gland, with well-defined borders. The lesion exhibited intense peripheral vascularization, in addition to inner vascularization at a lesser degree. The lesion at that time measured 1.6x1.6cm. Pleomorphic adenoma was suspected, but further investigation was suggested. All other salivary glands appeared normal and no enlarged lymph nodes were detected. A computer tomography (CT) scan of the upper neck and the parotids was performed four months later, without contrast, owing to the patient's allergy to the contrast media (Figure 1 b) . The scan revealed a large 4.1x3.8x3.5cm solid lesion of the left parotid gland's superficial lobe, with mild lobulation and speculation of its borders at its upper margin, as well as signs of infiltrative growth to the deep lobe of the left parotid. There were prominent lymph nodes from the left upper lateral group of the neck (IIa) up to 2x1cm. Small lymph nodes from other groups of the neck were also present. No obvious infiltration of deep or superficial fat planes of the neck were seen. The right parotid and submandibular glands appeared normal. Fine needle aspiration biopsy (FNAB) of the left parotid that was subsequently performed was suspicious for malignancy.
Surgery
It was decided to perform partial superficial left parotidectomy, which included excision of the tumor and lower parotid lobe, with preservation of the facial nerve ( Figures 1 c and d) . Regional lymph nodes were additionally resected.
Pathology
Pathological evaluation of the excised parotid gland revealed a blanched surgical specimen of hard consistency, comprised of connective and fatty tissue, measuring 5x4x3 cm, and surrounded by a thin fibrous capsule, with focal disruption and evidence of browniered foci. Immunohistochemistry was performed ( Figure  2 ), yielding CD10 (+), vimentin (+), PAX8 (+), RCC focally (+), CK7 (-), S100 (-), and Melan A (-). The final diagnosis of the renal metastatic CCRCC was established.
Discussion
We report a rare case of the CCRCC, a subtype of the RCC, metastasizing to the parotid gland more than five years following nephrectomy. The patient presented with a unilateral left parotid mass that was growing over the period of 18 months. After imaging investigation via US and CT, the initial impression concerning diagnosis was pleomorphic adenoma, although FNAB, as well as preceding imaging modalities were suspicious for malignancy and assisted in the planning of the operation. The patient underwent partial, left superficial parotidectomy with preservation of the facial nerve and the excised specimen was sent for pathological evaluation. The patient's history of CCRCC was considered central for the final diagnosis of metastatic CCRCC to the parotid, even after more than five years following nephrectomy. The patient remains under close-follow-up.
Due to its ability to spread via vascular, in addition to lymphatic channels, the RCC carries the ability to metastasize to distant and unpredictable locations of which metastasis to the parotid gland is extremely rare. The first cases of parotid involvement due to RCC metastases were reported by Patey et al. in 1965 7 . Since then, there have been limited reported cases of this phenomenon 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] . In their review of the literature, Lawlor et al. reported 45 cases of RCC metastasizing to the parotid, of which only 31 were complete case presentations 6 . They also reported that when FNAB was performed, it was diagnostic in only 3 of the cases. In 10 cases FNAB was non-diagnostic, while 18 cases did not mention the use of FNAB. In their case series, Park et al.
reported that 33% of cases with a parotid mass suspicious for RCC metastasis, were negative for malignancy or had a non-diagnostic yield via FNAB 17 . Eight of the articles reviewed by Lowler et al. stained positive for proximal nephron renal antigen, vimentin, CD10 and cytokeratin (CAM 5,2) 6 . CEA and cytokeratin 7 (CK7) were negative 6 . Similarly, the present patient was positive for CD10 and vimentin; while negative for CK7, excluding parotid origin of the tumour, as well as lung cancer metastases. The pathologist additionally assessed Melan A and S100, excluding melanoma metastases. Furthermore, this patient was positive for PAX8 and RCC, owing to a renal origin.
Since the initial diagnostic suspicion in this case was a primary parotid tumour, a pathological assessment of CK7, a highly important marker staining positive in primary parotid gland tumours, was performed. A few examples of these are clear cell carcinoma of the salivary glands, clear cell epithelial-myoepithelial carcinoma, clear cell myoepithelial carcinoma, and sebaceous carcinoma. Thus, by initially examining CK7, a parotid origin could be excluded.
